Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
Raghavendra Rao, General Surgeon at Vein Clinic, Founder of Best Surgical Education, LLC, shared a post on LinkedIn about a recent article by Maciej Wołkowski et al, published in JVS-VL, adding:
“Concomitant foam sclerotherapy of tributaries after truncal ablation with EVLA results in better varicose vein regression at 3 months in the short term and may result in a better quality of life at 6 months.
This comes at the cost of using too much or too concentrated sclerosant, resulting in foam sclerotherapy complications.
Non-randomized study published recently in JVS-VL.
The controversy continues regarding the need for tributary management after EVLA of the truncal veins, but a good percentage seem to need further treatments.
EVLA does have a substantial effect on tributary varicose veins.”
Title: Clinical trial of concomitant versus staged foam sclerotherapy of varicose veins following axial thermal ablation.
Authors: Maciej Wołkowski, Tomasz Urbanek, Krzysztof Wołkowski, Grzegorz Biolik, Wacław Kuczmik
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia